Cargando…

Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays

BACKGROUND: The single radial immunodiffusion (SRID) assay, the accepted method for determining potency of inactivated influenza vaccines, measures an immunogenic form of the influenza hemagglutinin. Nevertheless, alternative methods for measuring vaccine potency have been explored to address some o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasudevan, Anupama, Woerner, Amy, Schmeisser, Falko, Verma, Swati, Williams, Ollie, Weir, Jerry P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820428/ https://www.ncbi.nlm.nih.gov/pubmed/29152878 http://dx.doi.org/10.1111/irv.12528

Ejemplares similares

Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies
por: Verma, Swati, et al.
Publicado: (2017)

A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines
por: Schmeisser, Falko, et al.
Publicado: (2014)

Biolayer interferometry predicts ELISA performance of monoclonal antibody pairs for Plasmodium falciparum histidine-rich protein 2
por: Markwalter, C.F., et al.
Publicado: (2017)

Kinetic Titration Series with Biolayer Interferometry
por: Frenzel, Daniel, et al.
Publicado: (2014)

Biolayer interferometry for DNA-protein interactions
por: Barrows, John K., et al.
Publicado: (2022)

Influenza vaccine titer determination using biolayer interferometry (BLI)
por: Wheatley, David W, et al.
Publicado: (2015)

A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines
por: Schmeisser, Falko, et al.
Publicado: (2016)

Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring
por: Brady, Tyler, et al.
Publicado: (2022)

Characterization of antibody-antigen interactions using biolayer interferometry
por: Noy-Porat, Tal, et al.
Publicado: (2021)

Measuring the effects of macromolecular crowding on antibody function with biolayer interferometry
por: Kim, Dorothy M., et al.
Publicado: (2019)

Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4
por: Schuele, Carlotta, et al.
Publicado: (2023)

Applications of Surface Plasmon Resonance and Biolayer Interferometry for Virus–Ligand Binding
por: Murali, Shruthi, et al.
Publicado: (2022)

Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
por: Schmeisser, Falko, et al.
Publicado: (2015)

Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry
por: Dzimianski, John V., et al.
Publicado: (2020)

Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry
por: Dzimianski, John V., et al.
Publicado: (2020)

On-Site Biolayer Interferometry-Based Biosensing of Carbamazepine in Whole Blood of Epileptic Patients
por: Bian, Sumin, et al.
Publicado: (2021)

Suppressing Nonspecific Binding in Biolayer Interferometry Experiments for Weak Ligand–Analyte Interactions
por: Dubrow, Alyssa, et al.
Publicado: (2022)

Comparison of Enzyme-Linked Immunosorbent Assay, Surface Plasmon Resonance and Biolayer Interferometry for Screening of Deoxynivalenol in Wheat and Wheat Dust
por: Sanders, Melanie, et al.
Publicado: (2016)

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies
por: Cheung, Chung Y., et al.
Publicado: (2022)

Biolayer Interferometry Analysis for a Higher Throughput Quantification of In-Process Samples of a Rotavirus Vaccine
por: Carvalho, Sofia B., et al.
Publicado: (2022)

Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry
por: Chen, Qingqing, et al.
Publicado: (2022)

DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome()
por: Meseda, Clement A., et al.
Publicado: (2004)

Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens
por: Dennison, S. Moses, et al.
Publicado: (2018)

Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation
por: Gandolfini, Ilaria, et al.
Publicado: (2017)

2LTRZFP Interacts Specifically to HIV-1 DNA without Off-Target Effects as Determined by Biolayer Interferometry
por: Chupradit, Koollawat, et al.
Publicado: (2021)

Analyzing Dynamic Protein Complexes Assembled On and Released From Biolayer Interferometry Biosensor Using Mass Spectrometry and Electron Microscopy
por: Machen, Alexandra J., et al.
Publicado: (2018)

Biophysical Characterization of the Oligomeric States of Recombinant Immunoglobulins Type-M and Their C1q-Binding Kinetics by Biolayer Interferometry
por: Chouquet, Anne, et al.
Publicado: (2022)

Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies
por: Chae, Wonil, et al.
Publicado: (2019)

Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97
por: Bothe, Sebastian, et al.
Publicado: (2022)

Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it
por: Wang, Wei, et al.
Publicado: (2019)

Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes
por: Schmeisser, Falko, et al.
Publicado: (2007)

Measurements of SARS-CoV-2 antibody dissociation rate constant by chaotrope-free biolayer interferometry in serum of COVID-19 convalescent patients
por: Hao, Ying, et al.
Publicado: (2022)

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
por: Schmeisser, Falko, et al.
Publicado: (2012)

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
por: Bodle, Jesse, et al.
Publicado: (2023)

Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010–2011 Influenza Seasonal Vaccine
por: Guo, Zhu, et al.
Publicado: (2023)

High-throughput screening for amyloid-β binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC−DAD-Q/TOF-MS/MS
por: Guo, Minsong, et al.
Publicado: (2022)

Assaying the Potency of Influenza Vaccines
por: Minor, Philip D.
Publicado: (2015)

Assessment of in vitro potency of inactivated Newcastle disease oil-adjuvanted vaccines using hemagglutination test and blocking ELISA
por: Aly, Saleh E., et al.
Publicado: (2018)

The influence of variable-heavy chain families on IgG(2), (3), (4), FcγRs and B-cell superantigens protein G and L binding using biolayer interferometry
por: Deacy, Anthony M, et al.
Publicado: (2023)

Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies
por: Alvarado-Facundo, Esmeralda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u2japaffjg4lhcrs3con4844sc